Systematic Reviews
Copyright ©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. May 5, 2021; 12(3): 40-55
Published online May 5, 2021. doi: 10.4292/wjgpt.v12.i3.40
Table 2 Criteria used for the definition of liver injury
Criteria applied for liver injury definitionRef.Condition
Elevated ALT Tovo et al[47], 2006HIV/HCV
ALT > 2 × ULNMonteiro et al[25], 2012TB
ALT > 2.5 × ULNZaverucha-do-Valle et al[41], 2014; Kondo et al[49], 2008TB/smoker; HIV
ALT > 3 × ULNFernandes et al[68], 2015; Santos et al[53] 2013;TB; TB
ALT or AST > 2 × ULNAlves et al[59], 2011; de Castro et al[44], 2010AR; TB/HBV
ALT or AST > 3 × ULNHeinrich[24], 2014; Vieira et al[78], 2008; Uehara et al[76] 2005TB/ indigenous; TB; IMQ
ALT or AST > 3 × or BT > 1.5 ×Schultz et al[46], 2014TB/TX
ALT > 3 × ULN; BT > 2 ×Brito et al[64], 2014; Nader et al[45], 2010TB/HCV
ALT or AST > 3 × ULN; BT > 2 ×Lima Mde et al[65], 2012; Picon et al[66], 2002TB/HIV; TB
ALT ≥ 5 × LSN ou FA ≥ 2 × LSN ou ALT ≥ 3 × ULN e BT ≥ 2 × LSNPrado et al[27], 2019Gastro-hepatology conditions
(1) ALT > 3 × lower limit of normality; (2) ALT > 3 × ULN; (3) ALT > 3 × ULN and BT > 2 × ULNCoca et al[73], 2010TB/HIV
ALT or AST: (1) 1.25 a 2.5 × ULN; (2) 2.6 a 5 × ULN; (3) 5.1 a 10 × ULN; (4) > 10 × ULNAntonello et al[55], 2014HIV
ALT or AST: (1) 1.25 a 2.5 × ULN; (2) 2.6 a 5 × ULN; (3) 5.1 a 10 × ULN; (4) > 10 × ULN or BT – (1) 1.1 a 1.5 × ULN; (2) 1.6 a 2.5 × ULN; (3) 2.6 a 5.0 × ULN; (4) > 5.0 × ULNTomich et al[77], 2015TB/HIV
Altered ALT or AST (hepatotoxicity) and ALT or AST > 5 × (hepatitis)Gusmão Filho et al[43], 2001TB/children
ALT or AST > 3 × ULN and hepatitis syndromesTeixeira et al[52], 2011TB
AST > 3 × ULN and hepatitis syndromesSzklo et al[67], 2007TB/previous liver injury
Altered ALT, AST, AP or BTde Souza et al[79], 1996TB
Increase in liver function testsde-Medeiros et al[75], 1998LMA
Histological assessmentsSantos[63], 2013QT/HPTC
AST or ALT: (1) 1.1-4.9 × ULN; (2) 5.0-9.9 × ULN; (3) 10.0-15.0 × ULN; (4) > 15.0 × ULNGil et al[48], 2007HIV/child/adolescent
ALT > 2 times ULN or the ALT/AP ratio ≥ 5 or AP > 2 times ULN ALT/AP ratio ≤ 2 or ALT > 2 times ULN and ALT/AP ratio between 2 and 5Magalhães[26], 2015Several
ALT ou AST > 2 × LSN e BT > 1.3 mg/dLSantos et al[23], 2019TB
NISilva et al[22], 2019; Carvalho et al[74], 2014; Werner et al[61], 1989IBD; Ulcerative colitis; Grave’s disease